atropine and pralidoxime chloride
atropine and pralidoxime chloride is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand names including ATNAA atropine and pralidoxime chloride Auto-Injector, DuoDote. Available dosage form: kit.
Drug details
- Generic Name
- atropine and pralidoxime chloride
- Brand Names
- ATNAA atropine and pralidoxime chloride Auto-Injector, DuoDote
- Application Number
- NDA021175
- Sponsor
- Meridian Medical Technologies, LLC
- NDC Codes
- 3
- Dosage Forms
- KIT
- Routes
- INTRAMUSCULAR
Indications and Usage
1 INDICATIONS AND USAGE ATNAA is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having anticholinesterase activity in adults. ATNAA, a combination of atropine, a cholinergic muscarinic antagonist, and pralidoxime chloride, a cholinesterase reactivator, is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having anticholinesterase activity in adults. ( 1 )